Due to the COVID-19 pandemic, the global High Flow Oxygen Therapy Devices market size is estimated to be worth US$ 344.77 million in 2022 and is forecast to a readjusted size of US$ 363.36 million by 2028 with a CAGR of 0.88% during the review period
High Flow Oxygen Therapy Devices
Due to the COVID-19 pandemic, the global High Flow Oxygen Therapy Devices market size is estimated to be worth US$ 344.77 million in 2022 and is forecast to a readjusted size of US$ 363.36 million by 2028 with a CAGR of 0.88% during the review period
Report Sample includes: Table of Contents
List of Tables & Figures
Charts
Research Methodology
Get FREE Sample of this Report at https://www.intelmarketresearch.com/download-free-sample/6/high-flow-oxygen-therapy-devices-market
High Flow Oxygen Therapy (HFOT) is a type of respiratory therapy that delivers oxygen at a higher than normal flow rate. The goal of HFOT is to improve the amount of oxygen that reaches the lungs and bloodstream.
HFOT is often used for people who have difficulty breathing, such as those with COPD, cystic fibrosis, or other lung conditions. It can also be used for people who have had surgery or who are recovering from an injury.
HFOT can be provided through a variety of devices, including nasal cannulas, face masks, and ventilators. The type of device used will depend on the individual's needs.
HFOT can be beneficial for people who are struggling to breathe. It can help to improve oxygenation and reduce the work of breathing. HFOT can also be used to prevent respiratory problems from getting worse.
Fully considering the economic change by this health crisis, the Europe High Flow Oxygen Therapy Devices market is estimated at US$ 109.01 million in 2022, while the United States and China are forecast to reach US$ 125.33 million and US$ 41.92 million by 2028, respectively. The proportion of the United States is 36.79% in 2022, while Chinese percentage is 5.68%, and it is predicted that China market share will reach 11.54% in 2028, trailing a CAGR of 13.53% through the analysis period. As for the Europe High Flow Oxygen Therapy Devices landscape, Germany is projected to reach US$ 22.89 million by 2028.
Automatic Oxygen Adjustment accounting for 82.02% of the High Flow Oxygen Therapy Devices global market in 2021, is projected to value US$ 301.92 million by 2028, growing at a revised 1.02% CAGR in the forecast period (2022-2028). While Hospital Use segment is altered to a 1.01% CAGR throughout this forecast period (2022-2028) and will hold a share about 89.02% in 2028.
The global major manufacturers of High Flow Oxygen Therapy Devices include Fisher & Paykel Healthcare, TNI medical (Masimo), Micomme Medical, RMS Medical, Talent Medical Electronics, Vapotherm, Medline Industries (Teleflex), Inspired Medical (Vincent Medical), and Armstrong Medical , etc. In terms of revenue, the global 3 largest players accounted 82.40% market share of High Flow Oxygen Therapy Devices in 2021.
This report focuses on High Flow Oxygen Therapy Devices volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall High Flow Oxygen Therapy Devices market size by analyzing historical data and future prospect.
Segment Analysis:
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. By Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
By Company
Fisher & Paykel Healthcare
TNI medical (Masimo)
Micomme Medical
RMS Medical
Talent Medical Electronics
Vapotherm
Medline Industries (Teleflex)
Inspired Medical (Vincent Medical)
Armstrong Medical
Hamilton Medical
Great Group Medical
Beyond Medical
BMC Medical
Beijing Aeonmed
Segment by Type
Automatic Oxygen Adjustment
Manual Oxygen Adjustment
Segment by Application
Hospital Use
Homecare
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Thailand
Indonesia
Philippines
Bangladesh
Nepal
Other Regions
Europe
Germany
UK
France
